ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,95
0,35%
Dow Jones
40 003,59
0,34%
DAX
18 771,39
0,34%
Brent Oil
83,635
0,05%
Bitcoin
67 146,10
1,49%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM)

  7. Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM) Actualités

CRXM

Taxus Cardium Pharmaceut... (CE) (CRXM)

Taxus Cardium Pharmaceuticals Group Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CRXM
DateHeureSourceTitreSymboleSociété
14/04/202212h10Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
30/03/202223h27Edgar (US Regulatory)Annual Report (10-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
27/10/202115h17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
09/08/202122h59Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
28/07/202123h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
18/03/202119h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
01/03/202122h52Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
01/03/202122h47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
22/12/202021h24Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
04/12/201821h22Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
04/01/201816h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
30/03/201718h49Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
28/05/201512h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
27/03/201523h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
 Showing the most relevant articles for your search:USOTC:CRXM

Dernières Valeurs Consultées

COIN
PEPEBURNUST
Pepeburn
BOV
TUPYE265
TUPYE265 Ex:26,5
TG
CL4
H World
TG
SDL0
Cadoux
TG
PXK
Peyto Exploration & Deve...
TG
AM1
Argosy Minerals
USOTC
JLMCQ
Jlm Couture (CE)
BIT
P1TEI6
NLBNPIT1TEI6 20240621 32
TG
R5XA
Talphera
AMEX
RYDE
Ryde
COIN
APEDETH
Aped
TG
7EVB
Eolus Vind AB
TG
A07
Avance Gas
MRTX
ETGPETH
Ethereum Gold Project
AMEX
XXXX
Max S&P 500 4x Leveraged...
EU
AACHL
Credit Agricole Cib Fina...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés